Back to Search
Start Over
FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.
- Source :
- Medicine; Mar2018, Vol. 97 Issue 10, p1-8, 8p, 3 Color Photographs, 2 Charts
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 00257974
- Volume :
- 97
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 128560484
- Full Text :
- https://doi.org/10.1097/MD.0000000000010097